ARTICLE | Clinical News
Oncolym iodine labeled LYM-I: Will start a Phase II/III trial
October 17, 1994 7:00 AM UTC
Techniclone International Corp. (TCLN), Tustin, Calif Product: Oncolym iodine labeled LYM-I, a mouse monoclonal directed against an HLA-Dr variant Indication: Non-Hodgkin's B cell Iymphoma resistant ...